CAMP Latest Press Releases

-- May 21, 2026 --

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- May 14, 2026 --

CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder Globe Newswire 7:00 AM

-- May 7, 2026 --

CAMP4 Reports First Quarter 2026 Financial Results and Corporate Highlights Globe Newswire 4:05 PM

-- April 28, 2026 --

CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation Globe Newswire 8:00 AM

-- April 17, 2026 --

CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- March 24, 2026 --

CAMP4 Appoints Michael MacLean to its Board of Directors Globe Newswire 7:00 AM

-- March 6, 2026 --

CAMP4 to Participate in Upcoming Investor Conferences Globe Newswire 4:05 PM

-- March 5, 2026 --

CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights Globe Newswire 4:05 PM

-- February 20, 2026 --

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software